Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Adenosine
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
etrumadenant
(AB928) / Arcus Biosci, Gilead
KW-6356
/ Kyowa Kirin
ciforadenant
(CPI-444) / Corvus Pharma
imaradenant
(AZD4635) / AstraZeneca
neladenoson
(BAY 1067197) / Bayer
taminadenant
(NIR178) / Novartis
PBF-680
/ Palobiofarma
inupadenant
(EOS-850) / iTeos
vipadenant
(V2006) / BMS
lenrispodun
(ITI-214) / Intra-Cellular Therapies
FM101
/ Future Medicine
derenofylline
(SLV320) / AbbVie
EXS21546
/ Exscientia, Evotec
ILB-2109
/ Innolake Biopharma
PBF-677
/ Palobiofarma
T-62
/ Pfizer
capadenoson
(BAY 684986) / Bayer
trabodenoson/latanoprost
/ Rocket Pharma
Adenogesic
(adenosine IV) / Xsira Pharma
BVT-115959
/ SOBI
GW493838
/ GSK
NTM-006
/ Neumentum
Naturasone
(dehydroepiandrosterone sulphate) / EpiGenesis
OPA-6566
/ Kubota
PORT-6
/ Portage
PORT-7
/ Portage
TT-702
/ Teon Therap
UK 432097
/ Pfizer
evodenoson
(ATL313) / AbbVie
selodenoson
(DTI-0009) / Astellas
tecadenoson
(CVT-510) / Gilead
